TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer
Authors
Keywords
Prostate cancer, Cancer treatment, Transcription factors, Immunoblotting, Androgens, Gene expression, Castration, Doxycycline
Journal
PLoS One
Volume 14, Issue 9, Pages e0213488
Publisher
Public Library of Science (PLoS)
Online
2019-09-20
DOI
10.1371/journal.pone.0213488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer
- (2018) Miika Sainio et al. PATHOLOGY RESEARCH AND PRACTICE
- Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer
- (2016) Pablo Maroto et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study
- (2016) Neal D Shore et al. LANCET ONCOLOGY
- The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide
- (2016) Stefan Prekovic et al. MOLECULAR CANCER THERAPEUTICS
- Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling
- (2016) Alessia Calcagnì et al. eLife
- A Small-Molecule Antagonist of the -Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis
- (2015) L. Fang et al. CANCER RESEARCH
- Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer
- (2015) Eleni Efstathiou et al. EUROPEAN UROLOGY
- WNT5A Has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo
- (2015) Stefanie Thiele et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals
- (2015) Qiang Dang et al. Molecular Oncology
- Enzalutamide for patients with metastatic castration-resistant prostate cancer
- (2015) Wijdan Ramadan et al. OncoTargets and Therapy
- Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells
- (2015) Eugine Lee et al. PLoS One
- PD-L1 is highly expressed in Enzalutamide resistant prostate cancer
- (2015) Jennifer L. Bishop et al. Oncotarget
- Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
- (2015) Juan Miguel Mosquera et al. NEOPLASIA
- Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction
- (2014) G T Lee et al. BRITISH JOURNAL OF CANCER
- Enzalutamide: looking back at its preclinical discovery
- (2014) Yun-Sok Ha et al. Expert Opinion on Drug Discovery
- DLC1-dependent parathyroid hormone–like hormone inhibition suppresses breast cancer bone metastasis
- (2014) Yufeng Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone
- (2014) Daniel L. Suzman et al. PROSTATE
- What Are the Molecules Involved in Regulatory T-Cells Induction by Dendritic Cells in Cancer?
- (2013) Rodrigo Nalio Ramos et al. Clinical & Developmental Immunology
- REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
- (2013) C. Svensson et al. NUCLEIC ACIDS RESEARCH
- BMI1 Polycomb Group Protein Acts as a Master Switch for Growth and Death of Tumor Cells: Regulates TCF4-Transcriptional Factor-Induced BCL2 Signaling
- (2013) Hifzur Rahman Siddique et al. PLoS One
- Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
- (2012) Himisha Beltran et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling
- (2012) John O. DaSilva et al. PROSTATE
- Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome
- (2011) Azharuddin Sajid Syed Khaja et al. PLoS One
- Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes
- (2011) A. Aparicio et al. Cancer Discovery
- Small Cell Carcinoma of the Prostate
- (2009) Wenle Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Neuroendocrine-Derived Peptide Parathyroid Hormone-Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor
- (2009) J. DaSilva et al. CANCER RESEARCH
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Neuroendocrine differentiation in the progression of prostate cancer
- (2009) Akira Komiya et al. INTERNATIONAL JOURNAL OF UROLOGY
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Crosstalk between the Androgen Receptor and -Catenin in Castrate-Resistant Prostate Cancer
- (2008) G. Wang et al. CANCER RESEARCH
- An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells
- (2008) H. Wang et al. JOURNAL OF CELL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search